Literature DB >> 12072512

Immune control of the number and reactivation phenotype of cells latently infected with a gammaherpesvirus.

Scott A Tibbetts1, Linda F van Dyk, Samuel H Speck, Herbert W Virgin.   

Abstract

Despite active immune responses, gammaherpesviruses establish latency. In a related process, these viruses also persistently replicate by using a mechanism that requires different viral genes than acute-phase replication. Many questions remain about the role of immunity in chronic gammaherpesvirus infection, including whether the immune system controls latency by regulating latent cell numbers and/or other properties and what specific immune mediators control latency and persistent replication. We show here that CD8(+) T cells regulate both latency and persistent replication and demonstrate for the first time that CD8(+) T cells regulate both the number of latently infected cells and the efficiency with which infected cells reactivate from latency. Furthermore, we show that gamma interferon (IFN-gamma) and perforin, which play no significant role during acute infection, are essential for immune control of latency and persistent replication. Surprisingly, the effects of perforin and IFN-gamma are site specific, with IFN-gamma being important in peritoneal cells while perforin is important in the spleen. Studies of the mechanisms of action of IFN-gamma and perforin revealed that perforin acts primarily by controlling the number of latently infected cells while IFN-gamma acts primarily by controlling reactivation efficiency. The immune system therefore controls chronic gammaherpesvirus infection by site-specific mechanisms that regulate both the number and reactivation phenotype of latently infected cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12072512      PMCID: PMC136321          DOI: 10.1128/jvi.76.14.7125-7132.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell.

Authors:  G J Babcock; D Hochberg; A D Thorley-Lawson
Journal:  Immunity       Date:  2000-10       Impact factor: 31.745

2.  Latent antigen vaccination in a model gammaherpesvirus infection.

Authors:  E J Usherwood; K A Ward; M A Blackman; J P Stewart; D L Woodland
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

3.  Disruption of the murine gammaherpesvirus 68 M1 open reading frame leads to enhanced reactivation from latency.

Authors:  E T Clambey; H W Virgin; S H Speck
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages.

Authors:  E Flaño; S M Husain; J T Sample; D L Woodland; M A Blackman
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

5.  The murine gammaherpesvirus 68 v-cyclin is a critical regulator of reactivation from latency.

Authors:  L F van Dyk; H W Virgin; S H Speck
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  Differential methylation of Epstein-Barr virus latency promoters facilitates viral persistence in healthy seropositive individuals.

Authors:  E J Paulson; S H Speck
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  Mucosal shedding of human herpesvirus 8 in men.

Authors:  J Pauk; M L Huang; S J Brodie; A Wald; D M Koelle; T Schacker; C Celum; S Selke; L Corey
Journal:  N Engl J Med       Date:  2000-11-09       Impact factor: 91.245

8.  Regulation of antigen-specific CD8+ T cell homeostasis by perforin and interferon-gamma.

Authors:  V P Badovinac; A R Tvinnereim; J T Harty
Journal:  Science       Date:  2000-11-17       Impact factor: 47.728

9.  Novel cell type-specific antiviral mechanism of interferon gamma action in macrophages.

Authors:  R M Presti; D L Popkin; M Connick; S Paetzold; H W Virgin
Journal:  J Exp Med       Date:  2001-02-19       Impact factor: 14.307

10.  Control of gammaherpesvirus latency by latent antigen-specific CD8(+) T cells.

Authors:  E J Usherwood; D J Roy; K Ward; S L Surman; B M Dutia; M A Blackman; J P Stewart; D L Woodland
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

View more
  70 in total

1.  Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice.

Authors:  Shivaprakash Gangappa; Sharookh B Kapadia; Samuel H Speck; Herbert W Virgin
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Immature and transitional B cells are latency reservoirs for a gammaherpesvirus.

Authors:  Carrie B Coleman; Michael S Nealy; Scott A Tibbetts
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

3.  Effective vaccination against long-term gammaherpesvirus latency.

Authors:  Scott A Tibbetts; J Scott McClellan; Shivaprakash Gangappa; Samuel H Speck; Herbert W Virgin
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

4.  Maintenance of gammaherpesvirus latency requires viral cyclin in the absence of B lymphocytes.

Authors:  Linda F van Dyk; Herbert W Virgin; Samuel H Speck
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

5.  Critical role of CD4 T cells in an antibody-independent mechanism of vaccination against gammaherpesvirus latency.

Authors:  James Scott McClellan; Scott A Tibbetts; Shivaprakash Gangappa; Kelly A Brett; Herbert W Virgin
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

6.  An optimized CD4 T-cell response can control productive and latent gammaherpesvirus infection.

Authors:  Rebecca L Sparks-Thissen; Douglas C Braaten; Scott Kreher; Samuel H Speck; Herbert W Virgin
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

7.  T-cell responses to the M3 immune evasion protein of murid gammaherpesvirus 68 are partially protective and induced with lytic antigen kinetics.

Authors:  Joshua J Obar; Douglas C Donovan; Sarah G Crist; Ondine Silvia; James P Stewart; Edward J Usherwood
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

8.  Strain-dependent requirement for IFN-γ for respiratory control and immunotherapy in murine gammaherpesvirus infection.

Authors:  Ching-Yi Tsai; Zhuting Hu; Weijun Zhang; Edward J Usherwood
Journal:  Viral Immunol       Date:  2011-08       Impact factor: 2.257

9.  LXR Alpha Restricts Gammaherpesvirus Reactivation from Latently Infected Peritoneal Cells.

Authors:  P T Lange; C N Jondle; E J Darrah; K E Johnson; V L Tarakanova
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

10.  A replication-defective gammaherpesvirus efficiently establishes long-term latency in macrophages but not in B cells in vivo.

Authors:  Haiyan Li; Kazufumi Ikuta; John W Sixbey; Scott A Tibbetts
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.